// App-Quantinova.ai

Abstract TP234 : Delayed Administration Of A Repurposed Drug With Sigma 1 Receptor Activity Improves Stroke Outcomes In Male Rats

Researchers

Presenter

  • Derek Schreihofer

Principal Investigators

  • Dhwanil Dalwadi

  • Anthony Oppong-Gyebi

  • Daniel Metzger

  • Seongcheol Kim

Medical Centers

  • Pharmacology and Neuroscience, UNIVERSITY NORTH TEXAS HSC, Fort Worth, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Brain-derived neurotrophic factor

Drug/Treatment

  • Promethazine Hydrochloride

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved